To determine if such profibrotic factors could be identified in granulomas, expression levels of LGALS3, TREM2, GPNMB, SPP1, and CTS-D, -L, and -S were evaluated in the patient #1 biopsy across the previously defined five clusters. The gene discussed is GPNMB; the disease is Granuloma.